SCHEMBL4912282

SCHEMBL4912282

Cc1ccc(Cl)c(-c2ccc(Nc3c(Br)cnn3C)cc2)c1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
IGF1R P08069 1/20 0.38
KDR P35968 3/20 0.36
HTR2A P28223 6/20 0.35
HTR2C P28335 5/20 0.35
KDM4E B2RXH2 1/20 0.35
GALR3 O60755 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
BRD4 O60885 1/20 0.34
KAT2B Q92831 1/20 0.34
BRD9 Q9H8M2 1/20 0.34
HAVCR2 Q8TDQ0 1/20 0.34
GSK3B P49841 1/20 0.33
APP P05067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4908312 0.83 HAVCR2 (0.43) MEN1KMT2AKDRKDM4EGALR3
SCHEMBL4900772 0.82 KCNH2 (0.41) MEN1KMT2AHTR2AHTR2CKDM4E
SCHEMBL4901540 0.81 MEN1 (0.41) MEN1KMT2AHTR2AHTR2CKDM4E
SCHEMBL4908676 0.79 HTR2A (0.45) MEN1KMT2AHTR2AHTR2CKDM4E
SCHEMBL4910787 0.76 MAPT (0.50) MEN1KMT2AHTR2AHTR2CKDM4E
SCHEMBL4900743 0.76 PSEN1 (0.40) HTR2AHTR2C
SCHEMBL4910942 0.75 HTR2A (0.46) MEN1KMT2AHTR2AHTR2CKDM4E
SCHEMBL4913037 0.74 KDM4E (0.50) MEN1KMT2AHTR2AKDM4EGALR3
SCHEMBL4909053 0.74 MEN1 (0.39) MEN1KMT2AHTR2AHTR2CKDM4E
SCHEMBL4909812 0.74 HTR2A (0.41) MEN1KMT2AKDRHTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080015223-A1 Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto ARENA PHARMACEUTICALS, INC. (US) 2008-01-17 US claimed
WO-2006060762-A2 PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2006-06-08 WO claimed
US-20080015223-A1 Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto ARENA PHARMACEUTICALS, INC. (US) 2008-01-17 US disclosed
US-20080015223-A1 Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto ARENA PHARMACEUTICALS, INC. (US) 2008-01-17 US disclosed
US-20080015223-A1 Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto ARENA PHARMACEUTICALS, INC. (US) 2008-01-17 US disclosed
WO-2006060762-A2 PYRAZOLE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2006-06-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015223-A1 Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto HTR5A, HTR2A, HTR3A MEN1 3885/4885KMT2A 1390/4885IGF1R 2923/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.